CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $4.34M invested in Cellectar Biosciences in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

0.05% more ownership

Funds ownership: 0.02% → 0.07% (+0.05%)

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.01M
2
+$1.48M
3
+$231K
4
Renaissance Technologies
Renaissance Technologies
New York
+$144K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
+$4.85K

Top Sellers

1
-$42K
2
-$39.5K
3
-$63
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.01M
2
$1.48M
3
$268K
4
$231K
5
$191K
6
$77K
7
$37K
8
$22K
9
$9K
10
$6K
11
$5K
12
$1K
13
$59
14
–